Clinical Trial Update: PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND) [Phase 2]

View source ↗

Summary

Phase IIa trial evaluating a novel ondansetron formulation (OND-PR002) combined with immediate-release methylphenidate (OND003IND) for methamphetamine dependenc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Dependence
• Methamphetamine Dependence

Drugs mentioned

• OND-PR002 (novel ondansetron formulation) (ondansetron)
• OND003IND (immediate-release methylphenidate) (methylphenidate)

Snippet

Sponsor: Tong Lee | Conditions: Methamphetamine Dependence, Cocaine Dependence | Phase 2 | Status: COMPLETED